🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objectives: To provide safety data on revaccination with ADACEL® vaccine. ...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00347958
Treatments Being Tested
The study was designed to compare the safety and immunogenicity of DTap-IPV...
Status
Completed
Location
Multiple Locations
Start Date
2011-04
Trial ID
NCT01346293
Treatments Being Tested
This randomized phase II trial studies how well ibrutinib works when given ...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2016-01-12
Trial ID
NCT02518555
The purpose of this trial is to clinically confirm that the manufacturing p...
Status
Completed
Location
Multiple Locations
Start Date
2006-11
Trial ID
NCT00404651
The purpose of this study is to assess the efficacy and safety of repeating...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-01-01
Trial ID
NCT00610168
Treatments Being Tested
The aim of the study is to assess the immunogenicity and safety profile of ...
Status
Completed
Location
Multiple Locations
Start Date
2013-11
Trial ID
NCT01993173
The purpose of this study is to evaluate the safety of Adacel vaccine among...
Status
Active Not Recruiting
Location
Investigational Site
Start Date
2024-01-02
Trial ID
NCT06258057
Treatments Being Tested
This is a follow-up of the primary series vaccination schedule in Study A3L...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01444781
The aims of this study are to compare the immunogenicity and safety of the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2002-11
Trial ID
NCT00263692
Treatments Being Tested
The goal of this clinical trial is to investigate the safety and tetanus an...
Status
Completed
Location
ABO Plasma
Start Date
2023-05-05
Trial ID
NCT05662852
Treatments Being Tested